Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Contribution of inflammation to the pathology of idiopathic pulmonary arterial hypertension in children.

Hall S, Brogan P, Haworth SG, Klein N.

Thorax. 2009 Sep;64(9):778-83. doi: 10.1136/thx.2008.106435. Epub 2009 Jun 11.

PMID:
19525266
2.

Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.

Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ.

Circ Res. 2006 Feb 3;98(2):209-17. Epub 2005 Dec 15.

3.

Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.

Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, Diamond B, Barst RJ.

J Heart Lung Transplant. 2008 Jun;27(6):668-74. doi: 10.1016/j.healun.2008.02.009. Epub 2008 Apr 9.

PMID:
18503968
4.
5.

Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease.

Collins MH, Darragh RK, Caldwell RL, Turrentine MW, Brown JW.

J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1116-25.

PMID:
8719459
6.

Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment.

Hall SM, Davie N, Klein N, Haworth SG.

Eur Respir J. 2011 Oct;38(4):851-60. doi: 10.1183/09031936.00167010. Epub 2011 Mar 15.

7.

Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.

Hecker M, Zaslona Z, Kwapiszewska G, Niess G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D, Klepetko W, Lohmeyer J, Dimmeler S, Seeger W, Weissmann N, Schermuly RT, Kneidinger N, Eickelberg O, Morty RE.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):805-18. doi: 10.1164/rccm.200909-1367OC. Epub 2010 Jun 3.

PMID:
20522789
8.

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

Montani D, Perros F, Gambaryan N, Girerd B, Dorfmuller P, Price LC, Huertas A, Hammad H, Lambrecht B, Simonneau G, Launay JM, Cohen-Kaminsky S, Humbert M.

Am J Respir Crit Care Med. 2011 Jul 1;184(1):116-23. doi: 10.1164/rccm.201006-0905OC. Epub 2011 Feb 4.

PMID:
21471108
9.

[Apoptotic deregulation of endothelial cells and intimal proliferation in pulmonary hypertension of congenital heart disease].

Lévy M, Raisky O, Vouhé PR, Celermajer DS, Bonnet D, Israël-Biet D.

Arch Mal Coeur Vaiss. 2007 May;100(5):365-72. French.

PMID:
17646759
11.

CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension.

Ohta-Ogo K, Hao H, Ishibashi-Ueda H, Hirota S, Nakamura K, Ohe T, Ito H.

Pathol Int. 2012 Apr;62(4):219-25. doi: 10.1111/j.1440-1827.2011.02779.x. Epub 2012 Jan 10.

PMID:
22449225
12.

Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.

Song Y, Coleman L, Shi J, Beppu H, Sato K, Walsh K, Loscalzo J, Zhang YY.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H677-90. doi: 10.1152/ajpheart.91519.2007. Epub 2008 Jun 13. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1544.

13.

Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease.

Smadja DM, Gaussem P, Mauge L, Israël-Biet D, Dignat-George F, Peyrard S, Agnoletti G, Vouhé PR, Bonnet D, Lévy M.

Circulation. 2009 Jan 27;119(3):374-81. doi: 10.1161/CIRCULATIONAHA.108.808246. Epub 2009 Jan 12.

14.

Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.

Lévy M, Maurey C, Celermajer DS, Vouhé PR, Danel C, Bonnet D, Israël-Biet D.

J Am Coll Cardiol. 2007 Feb 20;49(7):803-10. Epub 2007 Feb 5.

15.

Morphology of the internal elastic lamina in arteries from pulmonary hypertensive patients: a confocal laser microscopy study.

Aiello VD, Gutierrez PS, Chaves MJ, Lopes AA, Higuchi ML, Ramires JA.

Mod Pathol. 2003 May;16(5):411-6.

16.

Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.

Li M, Vattulainen S, Aho J, Orcholski M, Rojas V, Yuan K, Helenius M, Taimen P, Myllykangas S, De Jesus Perez V, Koskenvuo JW, Alastalo TP.

Am J Respir Cell Mol Biol. 2014 Jun;50(6):1118-28. doi: 10.1165/rcmb.2013-0349OC.

PMID:
24433082
17.

Alterations of cellular bioenergetics in pulmonary artery endothelial cells.

Xu W, Koeck T, Lara AR, Neumann D, DiFilippo FP, Koo M, Janocha AJ, Masri FA, Arroliga AC, Jennings C, Dweik RA, Tuder RM, Stuehr DJ, Erzurum SC.

Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1342-7. Epub 2007 Jan 16.

18.

Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.

Sawada H, Saito T, Nickel NP, Alastalo TP, Glotzbach JP, Chan R, Haghighat L, Fuchs G, Januszyk M, Cao A, Lai YJ, Perez Vde J, Kim YM, Wang L, Chen PI, Spiekerkoetter E, Mitani Y, Gurtner GC, Sarnow P, Rabinovitch M.

J Exp Med. 2014 Feb 10;211(2):263-80. doi: 10.1084/jem.20111741. Epub 2014 Jan 20.

19.

BMP-dependent activation of caspase-9 and caspase-8 mediates apoptosis in pulmonary artery smooth muscle cells.

Lagna G, Nguyen PH, Ni W, Hata A.

Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1059-67.

20.

Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.

Morty RE, Nejman B, Kwapiszewska G, Hecker M, Zakrzewicz A, Kouri FM, Peters DM, Dumitrascu R, Seeger W, Knaus P, Schermuly RT, Eickelberg O.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1072-8. Epub 2007 Mar 8.

Supplemental Content

Support Center